- Covidien announces its intent to acquire Oridion Systems Ltd. in an all-cash transaction of USD 23 per Oridion share, representing total equity value of approximately USD 346 million for Oridion on a fully diluted basis
- Transaction has been unanimously recommended by each of Oridion’s and Covidien's Board of Directors
- Based on an exchange rate of CHF 0.9167 to USD 1.00 on April 4, 2012 the transaction price per Oridion share is equivalent to approximately CHF 21.08 and represents a premium of 91% to the volume-weighted average share price of the last 60 trading days and a premium of 76% to the closing price on April 4, 2012
- Covidien plans to integrate Oridion as a center of excellence in Capnography within its Medical Devices segment
News Release
